|
CH602664A5
(en)
|
1973-06-14 |
1978-07-31 |
Sandoz Ag |
2-Tert. amino-alkylamino-pyrimidine derivs.
|
|
ZA835878B
(en)
*
|
1982-08-23 |
1985-03-27 |
Warner Lambert Co |
Cardiotonic agents
|
|
GB2263639A
(en)
|
1992-01-28 |
1993-08-04 |
Merck & Co Inc |
Substituted pyrimidinones as neurotensin antagonists
|
|
DE4425616A1
(de)
*
|
1994-07-20 |
1996-01-25 |
Basf Ag |
Hydroxypyridoncarbonsäureamide, deren Herstellung und Verwendung
|
|
AU744518B2
(en)
|
1996-07-01 |
2002-02-28 |
Dr. Reddy's Laboratories Limited |
Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
|
|
CA2416248A1
(en)
|
2000-07-18 |
2002-01-24 |
Neurogen Corporation |
5-substituted 2-aryl-4-pyrimidinones
|
|
TW200300349A
(en)
|
2001-11-19 |
2003-06-01 |
Sankyo Co |
A 4-oxoqinoline derivative
|
|
US7166595B2
(en)
|
2002-05-09 |
2007-01-23 |
Cytokinetics, Inc. |
Compounds, methods and compositions
|
|
JP2005530806A
(ja)
|
2002-05-23 |
2005-10-13 |
メルク エンド カムパニー インコーポレーテッド |
有糸分裂キネシン阻害薬
|
|
JP2004339159A
(ja)
|
2003-05-16 |
2004-12-02 |
Sankyo Co Ltd |
４−オキソキノリン誘導体を含有する医薬組成物
|
|
WO2005026148A1
(en)
|
2003-09-08 |
2005-03-24 |
Takeda San Diego, Inc. |
Dipeptidyl peptidase inhibitors
|
|
JP2007510652A
(ja)
|
2003-11-03 |
2007-04-26 |
サイトキネティクス・インコーポレーテッド |
ピリミジン−４−オン化合物、組成物、および方法
|
|
WO2005060654A2
(en)
|
2003-12-19 |
2005-07-07 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
|
US7732613B2
(en)
|
2005-09-14 |
2010-06-08 |
Bristol-Myers Squibb Company |
Met kinase inhibitors
|
|
WO2007037543A1
(ja)
|
2005-09-29 |
2007-04-05 |
Banyu Pharmaceutical Co., Ltd. |
ビアリールアミド誘導体
|
|
US7728017B2
(en)
|
2005-11-30 |
2010-06-01 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of c-Met and uses thereof
|
|
WO2007124397A2
(en)
|
2006-04-21 |
2007-11-01 |
Trustees Of Boston University |
Ionic viscoelastics and viscoelastic salts
|
|
JP2007308441A
(ja)
|
2006-05-22 |
2007-11-29 |
Sumitomo Chemical Co Ltd |
含複素環化合物及びその用途
|
|
WO2008052863A2
(de)
|
2006-10-10 |
2008-05-08 |
Proionic Production Of Ionic Substances Gmbh & Co Keg |
Verfahren zur umsetzung von 1,3-hetero-aromatischen 2-carboxylaten mit wasser
|
|
WO2008052861A2
(de)
|
2006-10-10 |
2008-05-08 |
Proionic Production Of Ionic Substances Gmbh & Co Keg |
Verfahren zur herstellung von 1,3 -hetero-aromatischen carbonaten
|
|
TW200845994A
(en)
|
2007-01-12 |
2008-12-01 |
Smithkline Beecham Corp |
N-substituted glycine derivatives: prolyl hydroxylase inhibitors
|
|
CA2676173A1
(en)
|
2007-02-16 |
2008-08-28 |
Amgen Inc. |
Nitrogen-containing heterocyclyl ketones and their use as c-met inhibitors
|
|
EP3042660A3
(en)
|
2008-04-15 |
2016-10-26 |
RFS Pharma, LLC. |
Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections
|
|
EP2379684A2
(de)
|
2008-12-22 |
2011-10-26 |
Basf Se |
Mischungen hydrophober und hydrophiler ionischer flüssigkeiten und ihre verwendung in flüssigkeitsringverdichtern
|
|
CA2762680C
(en)
|
2009-05-21 |
2018-04-17 |
Chlorion Pharma, Inc. |
Methyl sulfanyl pyrmidmes useful as antiinflammatories, analgesics, and antiepileptics
|
|
WO2012020742A1
(ja)
|
2010-08-10 |
2012-02-16 |
塩野義製薬株式会社 |
新規複素環誘導体およびそれらを含有する医薬組成物
|
|
JP2014522570A
(ja)
|
2011-05-31 |
2014-09-04 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
電解質配合物
|
|
AU2012265219B2
(en)
|
2011-05-31 |
2017-02-16 |
Merck Patent Gmbh |
Compounds containing hydrido-tricyano-borate anions
|
|
US20140005181A1
(en)
*
|
2012-06-21 |
2014-01-02 |
Sanford-Burnham Medical Research Institute |
Small molecule antagonists of the apelin receptor for the treatment of disease
|
|
WO2014004676A1
(en)
|
2012-06-26 |
2014-01-03 |
Ironwood Pharmaceuticals, Inc. |
Use of faah inhibitors as neuroprotective agents in the cns
|
|
LT2897939T
(lt)
*
|
2012-09-21 |
2017-05-10 |
Sanofi |
Benzimidazolo karboksirūgšties amido dariniai metabolinių arba širdies ir kraujagyslių ligų gydymui
|
|
DE102012021452A1
(de)
|
2012-10-31 |
2014-04-30 |
Merck Patent Gmbh |
Salze mit Trihydroperfluoralkoxybutansulfonat- oder Trihydroperfluoralkoxypropansulfonat-Anion
|
|
KR20150135332A
(ko)
|
2013-03-14 |
2015-12-02 |
더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 |
미토콘드리아 알데히드 탈수소효소-2 조절인자들 및 이들의 사용 방법
|
|
WO2014207100A1
(en)
|
2013-06-27 |
2014-12-31 |
Basf Se |
A process for coating paper with cellulose using a solution containing cellulose
|
|
PE20160664A1
(es)
|
2013-06-27 |
2016-07-09 |
Pfizer |
Compuestos heteroaromaticos y su uso como ligandos d1 de dopamina
|
|
CA2930343C
(en)
|
2013-11-29 |
2021-06-08 |
Proionic Gmbh |
Method for curing an adhesive using microwave irradiation
|
|
US10570128B2
(en)
|
2014-05-28 |
2020-02-25 |
Sanford Burnham Prebys Medical Discovery Institute |
Agonists of the apelin receptor and methods of use thereof
|
|
WO2015188073A1
(en)
*
|
2014-06-06 |
2015-12-10 |
Research Triangle Institute |
Apelin receptor (apj) agonists and uses thereof
|
|
WO2016074757A1
(de)
|
2014-11-11 |
2016-05-19 |
Merck Patent Gmbh |
Verfahren zur herstellung von mono- und bis(perfluoralkyl)fluorophosphatsalzen und deren säuren
|
|
JP6358639B2
(ja)
|
2015-04-24 |
2018-07-18 |
塩野義製薬株式会社 |
６員複素環誘導体およびそれらを含有する医薬組成物
|
|
MA42145B1
(fr)
|
2015-05-20 |
2020-05-29 |
Amgen Inc |
Triazoles agonistes du récepteur apj
|
|
HRP20191327T1
(hr)
|
2015-06-03 |
2019-11-01 |
Bristol Myers Squibb Co |
4-hidroksi-3-(heteroaril)piridin-2-on apj agonisti za primjenju u liječenju kardiovaskularnih poremećaja
|
|
KR101711744B1
(ko)
|
2015-07-16 |
2017-03-02 |
경희대학교 산학협력단 |
옥사디아졸 유도체, 이의 제조방법 및 이를 포함하는 전자수송층
|
|
US10626096B2
(en)
|
2015-11-24 |
2020-04-21 |
Sanford Burnham Prebys Medical Discovery Institute |
Azole derivatives as apelin receptor agonist
|
|
AR106948A1
(es)
|
2015-12-04 |
2018-03-07 |
Bristol Myers Squibb Co |
Agonistas del receptor de apelina y método de uso
|
|
EP3390400B1
(en)
|
2015-12-16 |
2021-01-20 |
Bristol-Myers Squibb Company |
Heteroarylhydroxypyrimidinones as agonists of the apj receptor
|
|
MY189454A
(en)
|
2016-03-24 |
2022-02-14 |
Bristol Myers Squibb Co |
6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as apj agonists
|
|
KR102521955B1
(ko)
|
2016-06-14 |
2023-04-13 |
브리스톨-마이어스 스큅 컴퍼니 |
Apj 수용체 효능제로서의 4-히드록시-3-술포닐피리딘-2(1h)-온
|
|
WO2017218633A1
(en)
|
2016-06-14 |
2017-12-21 |
Bristol-Myers Squibb Company |
6-hydroxy-5-(phenyl/heteroarylsulfonyl)pyrimidin-4(1h)-one as apj agonists
|
|
KR102521956B1
(ko)
|
2016-10-14 |
2023-04-14 |
브리스톨-마이어스 스큅 컴퍼니 |
3-술포닐-5-아미노피리딘-2,4-디올 apj 효능제
|